Medicare Add-On Payments For New Dialysis Drugs Limited To ‘Innovative’ Products
Centers for Medicare and Medicaid Services narrows the types of drugs eligible for add-on payments in the Medicare end-stage renal program as it tries to balance efforts to promote innovation with controlling costs.
